Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind trial of recombinant human serum albumin versus human albumin in cirrhotic ascites
CTR20242974Phase 3Completed
- Sponsor
- Protogy
- Start
- Aug 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human serum albumin in Cirrhosis, ascites, sponsored by Protogy. Started Aug 2024; status: completed.
02
Drugs
recombinant human serum albumin
03
Conditions
Cirrhosisascites
Beyond the preview
Go deeper on CTR20242974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242974.